Daniel J. O'connor - Net Worth and Insider Trading

Daniel J. O'connor Net Worth

The estimated net worth of Daniel J. O'connor is at least $10 Million dollars as of 2024-11-29. Daniel J. O'connor is the President and CEO of Ambrx Biopharma Inc and owns about 342,845 shares of Ambrx Biopharma Inc (AMAM) stock worth over $10 Million. Daniel J. O'connor is the CEO of Advaxis Inc and owns about 246 shares of Advaxis Inc (ADXS) stock worth over $234. Daniel J. O'connor is also the Director of Seelos Therapeutics Inc and owns about 4 shares of Seelos Therapeutics Inc (SEELQ) stock worth over $1. Besides these, Daniel J. O'connor also holds OncoSec Medical Inc (ONCSQ) . Details can be seen in Daniel J. O'connor's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Daniel J. O'connor has not made any transactions after 2023-10-27 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Daniel J. O'connor

To

Daniel J. O'connor Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Daniel J. O'connor owns 7 companies in total, including Seelos Therapeutics Inc (SEELQ) , Advaxis Inc (ADXS) , and OncoSec Medical Inc (ONCSQ) among others .

Click here to see the complete history of Daniel J. O'connor’s form 4 insider trades.

Insider Ownership Summary of Daniel J. O'connor

Ticker Comapny Transaction Date Type of Owner
SEELQ Seelos Therapeutics Inc 2022-06-01 director
ADXS Advaxis Inc 2016-11-02 SVP & Legal & Business Dev Off
ONCSQ OncoSec Medical Inc 2021-04-30 director
LIMIT LIMIT 2021-12-20 director & Chief Executive Officer
LIMIT LIMIT 2023-07-05 director & President and CEO
LIMIT LIMIT 2021-12-20 director & Chief Executive Officer
LIMIT LIMIT 2023-10-27 director & President and CEO

Daniel J. O'connor Latest Holdings Summary

Daniel J. O'connor currently owns a total of 4 stocks. Among these stocks, Daniel J. O'connor owns 342,845 shares of Ambrx Biopharma Inc (AMAM) as of October 27, 2023, with a value of $10 Million and a weighting of 100%. Daniel J. O'connor owns 246 shares of Advaxis Inc (ADXS) as of November 2, 2016, with a value of $234 and a weighting of 0%. Daniel J. O'connor also owns 4 shares of Seelos Therapeutics Inc (SEELQ) as of June 1, 2022, with a value of $1 and a weighting of 0%. The other 1 stocks OncoSec Medical Inc (ONCSQ) have a combined weighting of 0% among all his current holdings.

Latest Holdings of Daniel J. O'connor

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
AMAM Ambrx Biopharma Inc 2023-10-27 342,845 28.00 9,599,660
ADXS Advaxis Inc 2016-11-02 246 0.95 234
SEELQ Seelos Therapeutics Inc 2022-06-01 4 0.33 1
ONCSQ OncoSec Medical Inc 2021-04-30 4,368 0.00 0

Holding Weightings of Daniel J. O'connor


Daniel J. O'connor Form 4 Trading Tracker

According to the SEC Form 4 filings, Daniel J. O'connor has made a total of 1 transactions in Ambrx Biopharma Inc (AMAM) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Ambrx Biopharma Inc is the sale of 50,012 shares on October 27, 2023, which brought Daniel J. O'connor around $491,118.

According to the SEC Form 4 filings, Daniel J. O'connor has made a total of 0 transactions in Advaxis Inc (ADXS) over the past 5 years. The most-recent trade in Advaxis Inc is the sale of 7 shares on November 2, 2016, which brought Daniel J. O'connor around $68,557.

According to the SEC Form 4 filings, Daniel J. O'connor has made a total of 1 transactions in Seelos Therapeutics Inc (SEELQ) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Seelos Therapeutics Inc is the acquisition of 4 shares on June 1, 2022, which cost Daniel J. O'connor around $9,760.

More details on Daniel J. O'connor's insider transactions can be found in the Insider Trading History of Daniel J. O'connor table.

Insider Trading History of Daniel J. O'connor

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Daniel J. O'connor Trading Performance

GuruFocus tracks the stock performance after each of Daniel J. O'connor's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Daniel J. O'connor is 22.68%. GuruFocus also compares Daniel J. O'connor's trading performance to market benchmark return within the same time period. The performance of stocks bought by Daniel J. O'connor within 3 months outperforms 3 times out of 6 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Daniel J. O'connor's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Daniel J. O'connor

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
2 out of 6 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 1.76 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 2.4 LIMIT LIMIT LIMIT LIMIT LIMIT

Daniel J. O'connor Ownership Network

Ownership Network List of Daniel J. O'connor

No Data

Ownership Network Relation of Daniel J. O'connor

Insider Network Chart

Daniel J. O'connor Owned Company Details

What does Seelos Therapeutics Inc do?

Who are the key executives at Seelos Therapeutics Inc?

Daniel J. O'connor is the director of Seelos Therapeutics Inc. Other key executives at Seelos Therapeutics Inc include director & See Remarks Raj Mehra , Chief Financial Officer Michael Joseph Golembiewski , and director & CEO & Secretary Richard W Pascoe .

Seelos Therapeutics Inc (SEELQ) Insider Trades Summary

Over the past 18 months, Daniel J. O'connor made no insider transaction in Seelos Therapeutics Inc (SEELQ). Other recent insider transactions involving Seelos Therapeutics Inc (SEELQ) include a net purchase of 83,000 shares made by Michael Joseph Golembiewski , and a net purchase of 75,757 shares made by Raj Mehra .

In summary, during the past 3 months, insiders sold 0 shares of Seelos Therapeutics Inc (SEELQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Seelos Therapeutics Inc (SEELQ) were sold and 1,240 shares were bought by its insiders, resulting in a net purchase of 1,240 shares.

Seelos Therapeutics Inc (SEELQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Seelos Therapeutics Inc Insider Transactions

No Available Data

Daniel J. O'connor Mailing Address

Above is the net worth, insider trading, and ownership report for Daniel J. O'connor. You might contact Daniel J. O'connor via mailing address: C/o Seelos Therapeutics, Inc., 300 Park Avenue, 12th Floor, New York Ny 10022.

Discussions on Daniel J. O'connor

No discussions yet.